Dis-Chem purchase of Baby City will bring in-store ante- and post-natal clinics

Organisation: Position: Deadline Date: Location:

Pharmacy group Dis-Chem has entered into a conditional arrangement to buy Baby City from its founder shareholders, the Aronoff family, for R430m, reports Fin24. Dis-Chem said that Michel Aronoff would continue to serve as MD of Baby City and current staff would be retained if the deal is given the greenlight by competition authorities and certain other conditions relating to employment contracts and leases are fulfilled.

“The acquisition is a great cultural fit and has been a target of ours for many years. The brands and businesses were built with similar philosophies, ensuring management team alignment as we take steps to unlock the value we see in the Baby City brand,” said Ivan Saltzman, Dis-Chem’s CEO.

Dis-Chem said if the transaction is approved, it would include Dis-Chem branded clinics at Baby City stores, offering ante and post-natal clinic services aimed at babies and toddlers. It has also identified another 30 possible sites for new stores.

The pharmacy chain said that Baby City had “continued to trade well relative to the COVID-19 lockdown environment,” which demonstrated “both the resilient nature of the industry and the inherent brand equity of the retailer”.

Full Fin24 report

Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.